RapidTEG observation suggests activation of factor VII may overcome argatroban-induced coagulopathy.
Schmitz
Michael L
ML
St Amour
Edgar D
ED
Harness
H Lynn
HL
McKamie
Wesley A
WA
Johnson
Charles E
CE
D001120:Arginine / Q000031:analogs & derivatives; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000201:enzymology* / Q000517:prevention & control; D002648:Child; D005167:Factor VII / Q000378:metabolism*; D005260:Female; D006801:Humans; D010875:Pipecolic Acids / Q000009:adverse effects*; D013449:Sulfonamides; D013916:Thrombelastography / Q000379:methods; D013997:Time Factors
D010875:Pipecolic Acids; D013449:Sulfonamides; D005167:Factor VII; D001120:Arginine; C031942:argatroban